Loading insider details...
Beta
Latest Form 4 (Oct 6, 2026): Purchase of 2,500 DYN shares, $40.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Dyne Therapeutics, Inc. (DYN) | Purchase | 2,500 | $40.0K |
| Jun 9, 2026 | Dyne Therapeutics, Inc. (DYN) | Purchase | 2,000 | $33.9K |
| Jun 5, 2026 | Dyne Therapeutics, Inc. (DYN) | Purchase | 2,500 | $43.7K |
| Jun 4, 2026 | ARCH CAPITAL GROUP LTD. (ACGL) | Sale | 3,000 | $59.0K |
| May 28, 2026 | Dyne Therapeutics, Inc. (DYN) | Purchase | 2,000 | $36.4K |
| May 22, 2026 | Dyne Therapeutics, Inc. (DYN) | Purchase | 2,500 | $42.8K |
| May 12, 2026 | ARCH CAPITAL GROUP LTD. (ACGL) | Sale | 2,000 | $34.3K |
| May 7, 2026 | ARCH CAPITAL GROUP LTD. (ACGL) | Grant/Award | 2,071 | n/a |
| Apr 1, 2026 | Dyne Therapeutics, Inc. (DYN) | Purchase | 2,000 | $34.2K |
| Mar 13, 2026 | Dyne Therapeutics, Inc. (DYN) | Purchase | 2,000 | $38.7K |